Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fuminari Akiyama"'
Autor:
Fuminari Akiyama, Natsumi Takahashi, Yuto Ueda, Shizuno Tada, Nobuyuki Takeuchi, Yusuke Ohno, Akio Kihara
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8291 (2024)
Ceramides are essential lipids for skin barrier function, and various classes and species exist in the human stratum corneum (SC). To date, the relationship between skin conditions and ceramide composition in healthy individuals has remained largely
Externí odkaz:
https://doaj.org/article/fc07a24d5e79449a9bf7b260efd53de6
Publikováno v:
Pharmaceuticals, Vol 5, Iss 10, Pp 1092-1102 (2012)
The blood-brain barrier is a substantial obstacle for delivering anticancer agents to brain tumors, and new strategies for bypassing it are sorely needed for brain tumor therapy. Intranasal delivery provides a practical, noninvasive method for delive
Externí odkaz:
https://doaj.org/article/08a0bc2daed44438a62c5a337f90049e
Autor:
Shino Kakizaki, Yuuki Takashima, Fuminari Akiyama, Takanori Kanazawa, Yasuo Seta, Toyofumi Suzuki, Takaki Niide, Hisako Ibaraki, Mami Kaneko, Shunsuke Shiraishi
Publikováno v:
International Journal of Pharmaceutics. 530:195-200
Recently, nose-to-brain delivery is a highly versatile route, which, in combination with novel drugs being developed for treating intractable CNS diseases, is a promising approach for the treatment of disorders. Furthermore, nano-sized drug carriers
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 5, Iss 10, Pp 1092-1102 (2012)
Pharmaceuticals; Volume 5; Issue 10; Pages: 1092-1102
Pharmaceuticals, Vol 5, Iss 10, Pp 1092-1102 (2012)
Pharmaceuticals; Volume 5; Issue 10; Pages: 1092-1102
The blood-brain barrier is a substantial obstacle for delivering anticancer agents to brain tumors, and new strategies for bypassing it are sorely needed for brain tumor therapy. Intranasal delivery provides a practical, noninvasive method for delive
Publikováno v:
Biomaterials. 34(36)
The potential for RNA-based agents to serve as effective therapeutics for central nerve systems (CNS) disorders has been successfully demonstrated in vitro. However, the blood-brain barrier limits the distribution of systemically administered therape
Publikováno v:
Biomaterials. 35:4247